BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4595363)

  • 1. [New aspects of the treatment of diabetic retinopathy].
    Regnault F; Barre Y; Rietzler X; Foucquier E; Aubert P; Molinier A; Zara M
    Therapeutique; 1973; 49(7):505-7. PubMed ID: 4595363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
    Plauchu M; Pousset G
    Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long term study of a new antidiabetic agent in 1183 cases].
    Riveline B
    Sem Hop Ther; 1974 Feb; 50(2):133-9. PubMed ID: 4612707
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
    Duhault J; Lebon F
    Arzneimittelforschung; 1972 Oct; 22(10):1686-90. PubMed ID: 4677057
    [No Abstract]   [Full Text] [Related]  

  • 7. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet adhesiveness and diamicron in human clinical practice].
    Daver J; Izarn P; Menache D; Paleirac G; Streiff F
    Therapeutique; 1973 Apr; 49(4):279-82. PubMed ID: 4775222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic retinopathy. Effects of gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1983; ():275-80. PubMed ID: 6358618
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy regimens in diabetic retinopathy].
    Mitulescu D; Selaru D; Ocian R
    Oftalmologia; 1999; 46(1):63-6. PubMed ID: 10641089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
    Vernet A; Fabre J; Zahnd G
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases].
    Uglesic A; Ljahnicky N
    Med Monatsschr; 1975 Sep; 29(9):408-11. PubMed ID: 1102900
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement in motor nerve conduction following treatment in newly diagnosed diabetics.
    Ward JD
    Adv Metab Disord; 1973; 2():Suppl 2:569-73. PubMed ID: 4720388
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the fructose therapy of diabetic retinopathy].
    Schrader KE; Mähr G; Neumann P
    Dtsch Med Wochenschr; 1966 Feb; 91(7):306-8. PubMed ID: 5323805
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of platelets in pathogenesis of diabetic retinopathy.
    Dobbie JG; Kwaan HC; Colwell JA; Suwanwela N
    Trans Am Acad Ophthalmol Otolaryngol; 1973; 77(1):OP43-7. PubMed ID: 4730082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.